MedTrace Logo

Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective Study

NCT03998332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2019-07-01

No results posted yet for this study

Summary

This is a retrospective study. 132 patients with LCNEC and combined LCNEC were included to the analysis. Patients were treated with radical, palliative or symptomatic intension between 2002-2018 in central and north-eastern centres in Poland. The group of patients consists of 47 women (36%) and 85 men (64%). Ratio of women to men is 1:1,81. The observation period ranged from 0 to 192 months.

Conditions

  • Survival Outcomes of Patients With Pulmonary LCNEC

Sponsors & Collaborators

  • Jaroslaw B. Cwikla, MD, PhD, Professor UWM

    lead OTHER

Principal Investigators

  • Jarosław B Ćwikła, MD, PhD · University of Warmia and Mazury

Eligibility

Min Age
18 Years
Max Age
86 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998332 on ClinicalTrials.gov